AstraZeneca

Global Clinical Program Lead, Immunology

AstraZeneca • $233K — $350K *
Pharmaceuticals & Biotech
5 - 7 years of experience
Job Overview by Ladders

Qualifications

  • Medical degree (MD or MD-PhD) with specialization in rheumatology or clinical immunology.
  • Minimum of 5 years in the pharmaceutical industry, leading clinical trials (Phase 2-4).
  • Knowledge of biostatistics, global regulatory standards, and pharmacovigilance.
  • Experience in clinical program design and development plans.
  • Strong presentation and communication skills for collaboration with stakeholders.
  • Ability to adapt quickly to new disease areas and projects.

Responsibilities

  • Design and deliver study concepts for clinical trials.
  • Drive clinical and scientific decisions within Global Study Teams.
  • Ensure compliance with Good Clinical Practice and patient safety.
  • Provide scientific input for study documents and protocols.
  • Lead safety surveillance and adverse event reporting processes.
  • Review and contribute to Clinical Study Reports with the GCH.
  • Educate new Global Study Team members on processes and expectations.
  • Identify risks and propose mitigation strategies for successful study delivery.

Benefits

  • Qualified retirement programs.
  • Paid time off including vacation and holidays.
  • Health, dental, and vision coverage.
  • Eligibility for short-term incentive bonuses and equity-based awards.
Full Job Description

As GCPL in Immunology, you will provide medical and scientific input into programs of cell therapy for clinical stage assets and provide program leadership that is passionate about rheumatology and clinical immunology. You will take responsibility for clinical development in cross-functional teams to support early to late phase clinical development activities. These include the creation of overall clinical development plans and clinical study design, writing study concepts and protocols, key study and health authority documentation, medical monitoring and ensuring timely delivery of studies.

In this role, you will be:

  • Responsible for study design concept delivery
  • Responsible for driving clinical and scientific decisions within Global Study Team remits together with other team members
  • Accountable for clinical, scientific, and ethical components of studies including patient safety on a study and/or program level in compliance with Good Clinical Practice
  • Accountable for scientific medical input to all relevant study documents (including and not limited to protocol, statistical analysis plan, amendments, informed consent, case report forms, safety, and risk-based monitoring plans) to ensure consistency within clinical program and alignment with scientific rationale.
  • Accountable for scientific medical content at international investigator meetings, and support to local Marketing Companies (MC) for country level activities
  • Accountable for safety surveillance on a study level and/or program level including the process for Adverse Events (AE)/ Serious AE reporting.
  • Reviews (with the GCH) the Clinical Study Report and plays key role in preparation and production of relevant sections (Introduction, Results, Discussion).
  • Accountable for induction and education of new Global Study Team members.
  • Work with GCH and TA leadership for identifying risks and proposing mitigation strategies to deliver successful phase IIb, III, IV or Life Cycle Management studies
  • Delivering clinical, scientific, and medical information/query responses to Regulatory Agencies, Ethic Committees, Marketing Companies (MCs), and investigators/sites, and provides clarifications as well as solves clinical, scientific, and medical issues in the Global Study Team

Leadership:

  • Clinical representative on indication in Global and Clinical Product Teams and/or sub-teams
  • Lead governance interactions in conjunction with or as delegated by the GCH such as DRACs, DRCs, PRCs
  • Co-lead the study and program strategy for publication development and approval of publications with the GCH

Qualifications and skills:

Essential

Medical degree (MD or MD-PhD) required, with specialist training or experience in rheumatology and/or clinical immunology

Minimum of 5 years in pharma industry, with experience in leading clinical trials to support approval (Phase 2-4)

Knowledge of biostatistics, global regulatory environment, and pharmacovigilance relevant to the role

Experience in leading or reviewing a clinical program to support an indication: design, clinical development plan and Target Product Profile.

Good presentation skills and effective communication with internal and external collaborators

Knowledge and experience to work across projects, with a fast-learning curve when moving into new disease areas

Desirable:

  • Experience in CAR-T or other engineered cell therapies, and/or T-cell engagers, in autoimmune or inflammatory indications.
  • Familiarity with cell-therapy operational constraints such as chain-of-identity/control and vein-to-vein logistics, and with CMC-clinical interfaces.
  • Experience in Sjogrens Disease or myositis
  • Experience working effectively with cross-functional partners across clinical development and commercial organizations.
  • Awareness of the evolving external landscape in rheumatology, including scientific, clinical, competitive, and regulatory developments.
  • Ability to travel nationally and internationally.

The annual base pay for this position ranges from $233,586.40 - $350,379.60 USD. Our positions offer eligibility for various incentivesan opportunity to receive short-term incentive bonuses, equity-based awards for salaried roles and commissions for sales roles. Benefits offered include qualified retirement programs, paid time off (i.e., vacation, holiday, and leaves), as well as health, dental, and vision coverage in accordance with the terms of the applicable plans.

Date Posted

05-Oct-2026

Closing Date

15-Oct-2026

About AstraZeneca

AstraZeneca is a British-Swedish multinational pharmaceutical company that specializes in the research, development, and manufacturing of prescription drugs. The company was formed in 1999 through the merger of Astra AB and Zeneca Group plc. AstraZeneca's products are used to treat a wide range of medical conditions, including cancer, cardiovascular disease, respiratory disease, and diabetes. The company has operations in over 100 countries and employs more than 76,000 people worldwide. AstraZeneca is committed to developing innovative medicines that improve the health and well-being of people around the world.
Learn more about AstraZeneca
Size
83,100 employees
Market Cap
$211.5 billion
Industry
Net Income
$3.1 billion
Founded
1999
5 Year Trend
+10.2%
Revenue
$26.6 billion
NASDAQ

Similar Jobs

More Jobs at AstraZeneca

More Pharmaceuticals & Biotech Jobs

Find similar Global Clinical Program Lead, Immunology jobs: